ATXN2 and corticobasal degeneration disorder: Ataxin-2 intermediate-length polyglutamine expansion is associated with increased ALS risk [12], and C9ORF72 intermediate-length repeat expansion is associated with corticobasal degeneration and ALS [11,23].